Jakub Kacer

Jakub Kacer

Auto-generated profile, based on publicly available information

Jakub Kacer

Lower Silesian Oncology Center, pl. Ludwika Hirszfelda 12, 53-413 Wroclaw, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JKJakub Kacer
Jakub Kacer
JCJakub Chołast
Jakub Chołast
WŁWiktoria Łuniewska
Wiktoria Łuniewska
MJMaurycy Jabłoński
Maurycy Jabłoński
JKJulia Kacer
Julia Kacer
MMMarta Modrzyk
Marta Modrzyk
Cutaneous malignant melanoma is one of the most aggressive skin cancers, with a steadily increasing incidence worldwide. Epidemiological studies suggest that airline pilots and cabin crew have approximately twice the melanoma risk of the general population. The aim of this review was to summarize current evidence regarding melanoma risk factors in flight personnel. A literature review was conducted using PubMed and related scientific databases, focusing on cohort studies and meta-analyses, and a report evaluating melanoma incidence and associated risk factors among airline crews. Current evidence indicates that melanoma risk in flight personnel is multifactorial. Major occupational factors include increased exposure to ultraviolet A (UVA) radiation at cruising altitude, cosmic ionizing radiation, and circadian rhythm disruption related to shift work and transmeridian travel. Lifestyle-related intermittent sun exposure during stopovers and holidays may further increase risk. Individual susceptibility is associated with fair skin phototypes, light hair color, and a high number of melanocytic naevi. Understanding these interacting occupational and individual factors may improve prevention strategies, including enhanced UV protection, occupational monitoring, and regular dermatological screening.

17 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JNJakub Niepokój
Jakub Niepokój
JKJulia Kacer
Julia Kacer
MJMaurycy Jabłoński
Maurycy Jabłoński
LKLaura Kobaka
Laura Kobaka
JCJakub Chołast
Jakub Chołast
MMMarta Modrzyk
Marta Modrzyk
Introduction: Wearable devices have become increasingly popular among runners for monitoring physiological and training-related parameters, including heart rate (HR), heart rate variability (HRV), resting heart rate, sleep, and training load. However, the reliability and practical interpretation of commercially derived metrics remain important considerations. Objective: This review aims to evaluate the reliability and practical utility of commercial wearable biosensors for monitoring training load, recovery, and potential signs of overreaching in runners. A secondary aim was to compare scientific evidence with information provided by device manufacturers and the way wearable-derived metrics are presented in popular online content. Methods: A review of scientific literature indexed in PubMed between 2016 and 2026 was conducted using keywords related to wearable technology, physiological monitoring, running, training load, overtraining, and endurance performance. Scientific evidence was considered alongside information provided on the official websites of selected wearable manufacturers and publicly available content from popular science sources and social media platforms, including YouTube, Instagram, and TikTok. Particular attention was given to the reliability of optical measurements, HR and HRV monitoring, and commercially derived training and recovery metrics. Results: The reviewed evidence indicates that commercial wearable devices can provide useful information for monitoring physiological responses to exercise and changes in training load. However, measurement accuracy varies according to the device, measurement method, and conditions of use. Commercial algorithms and derived metrics should therefore be interpreted cautiously, as they may not fully account for individual and contextual factors such as sleep, psychological stress, illness, or other sources of fatigue. The available evidence supports the use of wearable-derived data as an adjunct to, rather than a replacement for, subjective assessment of fatigue and recovery. Conclusions: Commercial wearable biosensors represent a useful and accessible tool for monitoring training load and recovery in runners. Their measurements and proprietary metrics should not be interpreted in isolation or regarded as diagnostic indicators of overreaching or overtraining. A comprehensive approach combining wearable-derived data with training history, subjective symptoms, sleep, recovery, and individual context may provide a more appropriate basis for training decisions and injury prevention.

17 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
WŁWiktoria Łuniewska
Wiktoria Łuniewska
MJMaurycy Jabłoński
Maurycy Jabłoński
LKLaura Kobaka
Laura Kobaka
JCJakub Chołast
Jakub Chołast
JKJakub Kacer
Jakub Kacer
MMMarta Modrzyk
Marta Modrzyk
Research objectives: Cutaneous melanoma is one of the most aggressive skin malignancies, characterized by a high potential for metastasis and a steadily increasing global incidence. While early-stage disease is associated with high cure rates, advanced melanoma has historically carried a poor prognosis, which has driven rapid advancements in both diagnostic technologies and systemic therapeutic strategies over the last decade. Aim: This narrative review aims to synthesize current international diagnostic and therapeutic guidelines (ESMO, NCCN, ASCO) and compare them with Polish clinical practice (PTOK), focusing on recent shifts in surgical management, the role of adjuvant therapies, and future perspectives in personalized medicine and artificial intelligence. Material and methods: The study is a narrative review based on the analysis of 21 recent peer-reviewed sources, including randomized controlled trials (RCTs), large-scale multicenter real-world studies from Poland, and the latest 2024 Clinical Practice Guidelines from the European Society for Medical Oncology and the National Comprehensive Cancer Network Key findings: International standards now emphasize a significant de-escalation of radical surgery, specifically recommending the omission of completion lymph node dissection (CLND) following a positive sentinel lymph node biopsy (SLNB) in favor of active ultrasound surveillance. Adjuvant systemic therapies including anti-PD-1 immunotherapy and targeted BRAF/MEK inhibitors have become the standard of care for high-risk patients, significantly improving relapse-free survival. Real-world data from Poland demonstrate a rapid alignment with these global trends, although challenges persist, as Polish patients are often diagnosed at more advanced stages, with a mean Breslow thickness of approximately 2.0 mm compared to <1.0 mm in Europe. Additionally, emerging deep learning architectures are showing outstanding potential, with diagnostic accuracies for melanoma detection exceeding 95%. Conclusions: Successful melanoma management requires a multidisciplinary approach and strict adherence to evidence-based international guidelines. The transition to early systemic adjuvant therapy allows for the safe de-escalation of surgical interventions without worsening patient prognosis. Future management will increasingly rely on personalized medicine through molecular biomarkers, mRNA neoantigen vaccines, and the clinical integration of artificial intelligence to improve early detection and treatment planning.

7 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JKJulia Kacer
Julia Kacer
JNJakub Niepokój
Jakub Niepokój
MJMaurycy Jabłoński
Maurycy Jabłoński
LKLaura Kobaka
Laura Kobaka
JCJakub Chołast
Jakub Chołast
MMMarta Modrzyk
Marta Modrzyk
Background: The female menstrual cycle features dynamic hormonal fluctuations affecting metabolic parameters, the neuromuscular system, and the biomechanics of the musculoskeletal system. With the advancement of women's sports, the popularization of rigorous training periodization models based on cycle phases (cycle syncing) can be observed on social media. Unfortunately, many of these recommendations rely on anecdotal reports, and the research landscape is further complicated by the widespread use of oral hormonal contraceptives among female athletes. Objective: This study aims to critically evaluate the validity of training periodization according to the menstrual cycle phase in women by comparing evidence-based medicine (EBM) guidelines with the narrative promoted across mass social media. Methods: A systematic review of scientific literature across PubMed and Web of Science databases was performed for the period up to 2026. Studies assessing the impact of hormonal fluctuations on strength parameters, performance metrics (VO2max), joint laxity (anterior cruciate ligament - ACL injury risk), and psychophysical indicators in naturally training women and oral contraceptive users were analyzed. Concurrently, a qualitative analysis of top trends and claims on TikTok, Instagram, and YouTube was carried out. Results: Analysis of scientific literature indicated the stability of performance metrics (VO2max) and strength indicators across the physiological cycle for most women, undermining the validity of drastic and rigid training load changes promoted online. However, hormonal fluctuations correlate with variability in ligament laxity (increased susceptibility to ACL injuries during the ovulatory phase) and subjective fatigue in the late luteal phase. It was also shown that hormonal contraception abolishes natural sex hormone fluctuations, rendering universal internet templates non-functional. Conclusions: Current EBM guidelines do not support rigid training periodization based strictly on the menstrual calendar, contradicting the dominant mass media trend. Uncritical implementation of schematic training restrictions and dietary constraints can negatively affect athletic progress, bone mineral density, and the relationship with food. The most justified, safe, and scientifically supported alternative to internet templates is individual effort autoregulation, based on ongoing monitoring of psychophysical readiness.

31 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MJMaurycy Jabłoński
Maurycy Jabłoński
LKLaura Kobaka
Laura Kobaka
KJKlaudia Jurga
Klaudia Jurga
JCJakub Chołast
Jakub Chołast
JKJakub Kacer
Jakub Kacer
MMMarta Modrzyk
Marta Modrzyk
Background: nasal respiration is the only true physiological breathing mechanism, providing essential ventilation, air conditioning, and defensive filtration for the lower airways. For professional athletes, rhinosinusal health is one of the determinants of performance, yet sport-specific environments often disrupt this homeostasis, leading to a clinical state often described as the “athlete’s nose”. Purpose: to evaluate the pathophysiology of exercise-induced rhinosinusal alterations across various sport categories and to synthesize evidence-based management strategies - incorporating mechanical, surgical, and pharmacological interventions - to optimize athletic performance and cardiovascular safety. Methods: a structured literature review was conducted with reference to PRISMA guidelines for search transparency. Data were synthesized from clinical studies involving professional athletes (swimmers, skiers, runners, and boxers) and compared against established assessment protocols, including, the International Consensus Statement on Rhinosinusistis (ICAR-RS 2021), EPOS 2020, and the SARAH assessment framework. Findings were narratively synthesized by sport-specific pathophysiology. Results: significant alterations in nasal physiology were identified. Swimmers showed the most severe deviations, with a mean mucociliary transport time (MCTt) of 27.4±4.97 min compared with the 13-minute norm (p<0.0001), linked to chlorine-induced neurogenic inflammation and elevated Substance P. Nasal breathing was found to enhance physical endurance and may protect against cardiac fibrosis by reducing sympathetic drive. Interventions, including internal nasal dilators, septoplasty, and post-operative topical furosemide, showed significant benefits for performance and symptom control. Conclusions: rhinosinusal disruptions are sport-specific and significantly impair physical capacity. Multimodal management and systematic screening are essential for maintaining competitive fitness.

25 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KJKlaudia Jurga
Klaudia Jurga
MJMaurycy Jabłoński
Maurycy Jabłoński
LKLaura Kobaka
Laura Kobaka
JCJakub Chołast
Jakub Chołast
WŁWiktoria Łuniewska
Wiktoria Łuniewska
DKDawid Kwiatkowski
Dawid Kwiatkowski
Dyslipidemia is one of the top modifiable causes of ASCVD‚ which is still the leading cause of death worldwide․ Statins are first line treatment‚ but potentially reversible obstacles to effective treatment include patient discontinuation‚ statin intolerance‚ concern about statin-related adverse effects‚ and residual cardiometabolic risk in patients who are apparently well treated with statins․ Over the years‚ nutraceuticals have also been of interest as adjunctive agents affecting lipids‚ but also glucose metabolism‚ inflammation‚ intestinal absorption of cholesterol‚ and vascular biology․ Today‚ their role is not to replace established pharmacological therapy but to complement it in selected patients with low or moderate cardiovascular risk‚ or patients who are statin-intolerant or statin-ineligible (Penson & Banach‚ 2020; Cicero et al․‚ 2017; Banach et al․‚ 2018)․ Here we review the clinical and mechanistic evidence for selected nutraceuticals used for dyslipidemia and other components of the metabolic syndrome․ These include red yeast rice‚ soluble fiber‚ omega-3 fatty acids‚ phytosterols‚ berberine‚ bergamot polyphenols‚ curcumin‚ and other common functional foods․ We also describe issues related to the quality of preparation‚ inter-individual variability in pharmacokinetics and -dynamics‚ bioavailability‚ untoward side effects‚ and the relationship of surrogate marker changes to hard cardiovascular outcomes․ An additional aspect sometimes discussed includes the therapeutic dilemma of statin intolerance and the nocebo effect in the clinical setting (Banach et al‚ 2015; Banach et al․‚ 2018; Mach et al․‚ 2020)․ In general‚ there is support for the use of several nutraceuticals in the primary prevention setting‚ in partially statin intolerant patients and on top of standard therapies․ Even though the effect sizes are not dramatic‚ they can be clinically meaningful in defined patient populations․ On the other hand‚ this field is still marred by a lack of product standardization‚ poor quality of studies‚ and a lack of large outcome-driven clinical trials․ Nutraceuticals should be seen as one component of a thorough prevention strategy and not a replacement for evidence-based pharmacotherapy․ Nutraceuticals used to lower dyslipidemia are red yeast rice‚ soluble fiber‚ omega-3 fatty acids‚ phytosterols‚ and berberine․ Objective: To evaluate the role of nutraceuticals in the management of dyslipidemia and to assess their effects on lipid metabolism based on currently available clinical evidence. Materials and methods: A thorough review of published peer-reviewed studies on the pharmacological role of nutraceuticals in the treatment of dyslipidemia and in the modulation of lipid metabolism was conducted‚ which included meta-analyzes‚ systematic reviews‚ randomized controlled trials‚ placebo-controlled clinical studies‚ expert position papers and international guidelines to evaluate their efficacy‚ safety‚ and application in dyslipidemic patients․ We focused on the nutraceuticals with lipid-lowering effects‚ specifically omega-3 fatty acids‚ red yeast rice‚ plant sterols and stanols‚ soluble fiber‚ berberine‚ bergamot‚ cocoa products‚ curcumin‚ coenzyme Q10‚ and nutraceutical combinations․ The inclusion criteria were studies that addressed the management of dyslipidemia with lipid-specific endpoints‚ of which total cholesterol‚ low-density lipoprotein cholesterol (LDL-C)‚ high-density lipoprotein cholesterol (HDL-C)‚ and triglycerides were the most relevant ones․ Evidence regarding the putative mechanisms of action of nutraceuticals on lipid metabolism‚ as well as the effect of nutraceuticals as an add-on or alternative lipid-lowering therapy‚ was particularly highlighted․ Results were narratively synthesized based on the type of nutraceutical and the reported effect on lipid profile and cardiometabolic risk outcomes.